Generex Biotechnology receives Australian patent
Company Expands Drug Delivery Platform Patent Portfolio
08-Sep-2005
The patent covers formulations for the delivery of peptidic drugs, vaccines, and hormones and enhances the Company's existing drug delivery patent portfolio. The Company currently holds an aggregate of 70 patents (17 of which are United States patents) and has an aggregate of 60 patent applications pending in various jurisdictions.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Smoking affects fracture healing
Go to page
UC Davis study confirms link between advanced maternal age and autism - Advanced paternal age is a risk only when the mother is younger
Go to page
List_of_gelechiid_genera:_N
Go to page
List_of_geometrid_genera:_O
Go to page
DNA_microarray
Go to page
Oxford University researchers and local company work together to accelerate HIV vaccine research
Go to page
Kyowa Hakko Develops a New Manufacturing Technology for Amino Acid Dimers (di-peptides) - A Significant Play in the Growing High Value-added Amino Acid Industry
Go to page
List_of_hesperiid_genera:U
Go to page
Eisai Announces Completion of Acquisition of Morphotek
Go to page
Orchid Cellmark launches new DNA testing service to confirm native american tribal membership
Go to page
Addex Achieves First Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc. - Collaboration Targets a Non-Dopaminergic Approach to Treating Parkinson's Disease
Go to page
List_of_lycaenid_genera:_U
Go to page